Heribert Bohlen
- Molecular Biology top 5%
- Immunology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Volker DiehlHans TeschOliver ManzkeBernd K. FleischmannWilhelm BlochJuergen HeschelerMartin R. WeihrauchEugen Kolossov
- Topics
- Monoclonal and Polyclonal Antibodies Research (26 papers)Lymphoma Diagnosis and Treatment (17 papers)CAR-T cell therapy research (13 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Heribert Bohlen
77 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 129
- Molecular Biology 1.3k
- Immunology 1.1k
- Radiology, Nuclear Medicine and Imaging 797
- Oncology 784
- Pathology and Forensic Medicine 774
Countries citing papers authored by Heribert Bohlen
This map shows the geographic impact of Heribert Bohlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heribert Bohlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heribert Bohlen more than expected).
Fields of papers citing papers by Heribert Bohlen
This network shows the impact of papers produced by Heribert Bohlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heribert Bohlen. The network helps show where Heribert Bohlen may publish in the future.
Co-authorship network of co-authors of Heribert Bohlen
This figure shows the co-authorship network connecting the top 25 collaborators of Heribert Bohlen. A scholar is included among the top collaborators of Heribert Bohlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heribert Bohlen. Heribert Bohlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 44 | |
| 3 | 33 | |
| 4 | 60 | |
| 5 | 108 | |
| 6 | 0 | |
| 7 | 15 | |
| 8 | 15 | |
| 9 | 22 | |
| 10 | 82 | |
| 11 | 12 | |
| 12 | 18 | |
| 13 | 16 | |
| 14 | 15 | |
| 15 | 32 | |
| 16 | 26 | |
| 17 | 23 | |
| 18 | 50 | |
| 19 | 8 | |
| 20 | 28 |
About Heribert Bohlen
Heribert Bohlen is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 81 papers that have together received 3.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (26 papers), Lymphoma Diagnosis and Treatment (17 papers) and CAR-T cell therapy research (13 papers). The work is most often cited by research in Immunology (1.1k citations), Genetics (545 citations) and Pathology and Forensic Medicine (774 citations). Heribert Bohlen has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Volker Diehl, Hans Tesch, Oliver Manzke, Bernd K. Fleischmann, Wilhelm Bloch, Juergen Hescheler, Martin R. Weihrauch, Eugen Kolossov, Dieter Kube and Ralf Kettenhofen. Their work appears in journals such as Circulation, Journal of Clinical Oncology and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.